E Nutescu

Summary

Affiliation: University of Illinois at Chicago
Country: USA

Publications

  1. ncbi Choosing the appropriate antithrombotic agent for the prevention and treatment of VTE: a case-based approach
    Edith A Nutescu
    Antithrombosis Center, Department of Pharmacy Practice, College of Pharmacy, The University of Illinois at Chicago, Chicago, IL 60612 7230, USA
    Ann Pharmacother 40:1558-71. 2006
  2. ncbi Low-molecular-weight heparins in renal impairment and obesity: available evidence and clinical practice recommendations across medical and surgical settings
    Edith A Nutescu
    Antithrombosis Center, Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, IL 60612, USA
    Ann Pharmacother 43:1064-83. 2009
  3. ncbi Integrating electronic health records in the delivery of optimized anticoagulation therapy
    Edith A Nutescu
    University of Illinois at Chicago, IL, USA University of Illinois Hospital and Health Sciences System, IL, USA
    Ann Pharmacother 49:125-6. 2015
  4. ncbi Oral anticoagulant therapies: balancing the risks
    Edith A Nutescu
    College of Pharmacy, University of Illinois at Chicago, Chicago, IL 60612, USA
    Am J Health Syst Pharm 70:S3-11. 2013
  5. pmc Delivery of optimized inpatient anticoagulation therapy: consensus statement from the anticoagulation forum
    Edith A Nutescu
    Department of Pharmacy Practice, Center for Pharmacoepidemiology and Pharmacoeconomic Research, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, USA
    Ann Pharmacother 47:714-24. 2013
  6. ncbi Economic considerations in managing patients with chronic stable angina
    Edith A Nutescu
    University of Illinois at Chicago, College of Pharmacy and Medical Center, 833 South Wood St, MC 886, Rm 164, Chicago, IL 60612, USA
    J Manag Care Pharm 12:S17-21. 2006
  7. ncbi Warfarin anticoagulation after total hip or total knee replacement: clinical and resource-utilization outcomes in a university-based antithrombosis clinic
    Edith A Nutescu
    Department of Pharmacy Practice and Center for Pharmacoeconomic Research, College of Pharmacy, University of Illinois at Chicago, Chicago, IL 60612, USA
    Am J Health Syst Pharm 70:423-30. 2013
  8. ncbi Pharmacoeconomic implications of thromboprophylaxis with new oral anticoagulants after total hip or knee replacement in the USA
    Edith A Nutescu
    University of Illinois at Chicago, College of Pharmacy, Center for Pharmacoeconomic Research, Department of Pharmacy Practice and Administration, 833 South Wood Street, Room 164 2, Mail Code 886, Chicago, IL 60612, USA
    Expert Opin Pharmacother 14:525-34. 2013
  9. ncbi Apixaban: a novel oral inhibitor of factor Xa
    Edith Nutescu
    Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, 833 South Wood Street, MC 886, Room 164, Chicago, IL 60612, USA
    Am J Health Syst Pharm 69:1113-26. 2012
  10. ncbi Economic evaluation of the use of enoxaparin in non-ST-elevation acute coronary syndrome
    Edith A Nutescu
    Antithrombosis Center, The University of Illinois at Chicago, College of Pharmacy, Department of Pharmacy Practice, 833 S Wood Street, MC 886, Room 164, Chicago, Illinois 60612 7230, USA
    Expert Opin Pharmacother 9:95-105. 2008

Detail Information

Publications67

  1. ncbi Choosing the appropriate antithrombotic agent for the prevention and treatment of VTE: a case-based approach
    Edith A Nutescu
    Antithrombosis Center, Department of Pharmacy Practice, College of Pharmacy, The University of Illinois at Chicago, Chicago, IL 60612 7230, USA
    Ann Pharmacother 40:1558-71. 2006
    ..To review the risk of venous thromboembolism (VTE) in various patient populations and evaluate the agents available for the prevention and treatment of VTE using a case-based approach...
  2. ncbi Low-molecular-weight heparins in renal impairment and obesity: available evidence and clinical practice recommendations across medical and surgical settings
    Edith A Nutescu
    Antithrombosis Center, Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, IL 60612, USA
    Ann Pharmacother 43:1064-83. 2009
    ..To develop practical recommendations for the use of low-molecular-weight heparins (LMWHs) as prophylaxis and treatment of venous thromboembolism and acute coronary syndromes in patients with impaired renal function or obesity...
  3. ncbi Integrating electronic health records in the delivery of optimized anticoagulation therapy
    Edith A Nutescu
    University of Illinois at Chicago, IL, USA University of Illinois Hospital and Health Sciences System, IL, USA
    Ann Pharmacother 49:125-6. 2015
    ....
  4. ncbi Oral anticoagulant therapies: balancing the risks
    Edith A Nutescu
    College of Pharmacy, University of Illinois at Chicago, Chicago, IL 60612, USA
    Am J Health Syst Pharm 70:S3-11. 2013
    ....
  5. pmc Delivery of optimized inpatient anticoagulation therapy: consensus statement from the anticoagulation forum
    Edith A Nutescu
    Department of Pharmacy Practice, Center for Pharmacoepidemiology and Pharmacoeconomic Research, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, USA
    Ann Pharmacother 47:714-24. 2013
    ....
  6. ncbi Economic considerations in managing patients with chronic stable angina
    Edith A Nutescu
    University of Illinois at Chicago, College of Pharmacy and Medical Center, 833 South Wood St, MC 886, Rm 164, Chicago, IL 60612, USA
    J Manag Care Pharm 12:S17-21. 2006
    ....
  7. ncbi Warfarin anticoagulation after total hip or total knee replacement: clinical and resource-utilization outcomes in a university-based antithrombosis clinic
    Edith A Nutescu
    Department of Pharmacy Practice and Center for Pharmacoeconomic Research, College of Pharmacy, University of Illinois at Chicago, Chicago, IL 60612, USA
    Am J Health Syst Pharm 70:423-30. 2013
    ..Clinical and resource-utilization outcomes associated with warfarin anticoagulation after major orthopedic surgery were evaluated...
  8. ncbi Pharmacoeconomic implications of thromboprophylaxis with new oral anticoagulants after total hip or knee replacement in the USA
    Edith A Nutescu
    University of Illinois at Chicago, College of Pharmacy, Center for Pharmacoeconomic Research, Department of Pharmacy Practice and Administration, 833 South Wood Street, Room 164 2, Mail Code 886, Chicago, IL 60612, USA
    Expert Opin Pharmacother 14:525-34. 2013
    ..This article explores whether newer oral anticoagulants can reduce costs of VTE prophylaxis and therapy...
  9. ncbi Apixaban: a novel oral inhibitor of factor Xa
    Edith Nutescu
    Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, 833 South Wood Street, MC 886, Room 164, Chicago, IL 60612, USA
    Am J Health Syst Pharm 69:1113-26. 2012
    ..The pharmacology, pharmacokinetics, efficacy, and safety of apixaban are reviewed...
  10. ncbi Economic evaluation of the use of enoxaparin in non-ST-elevation acute coronary syndrome
    Edith A Nutescu
    Antithrombosis Center, The University of Illinois at Chicago, College of Pharmacy, Department of Pharmacy Practice, 833 S Wood Street, MC 886, Room 164, Chicago, Illinois 60612 7230, USA
    Expert Opin Pharmacother 9:95-105. 2008
    ..Based on published economic analyses, the incremental drug costs of LMWH compared with UFH are compensated for by savings in medical-resource costs secondary to reducing ischemic events in NSTE-ACS patients...
  11. ncbi New anticoagulant agents: direct thrombin inhibitors
    Edith A Nutescu
    Department of Pharmacy Practice, Antithrombosis Center, University of Illinois at Chicago, College of Pharmacy and Medical Center, 833 South Wood Street, M C 886, Room 164, Chicago, IL 60612, USA
    Cardiol Clin 26:169-87, v-vi. 2008
    ....
  12. ncbi A pharmacologic overview of current and emerging anticoagulants
    Edith A Nutescu
    Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, 60612, USA
    Cleve Clin J Med 72:S2-6. 2005
    ..Because of their convenience and ease of use, some of these novel compounds are competing with the traditional anticoagulants and are needed additions to the antithrombotic arsenal...
  13. ncbi Strategies for cost-effective prevention and treatment of venous thromboembolism. Introduction
    Edith A Nutescu
    The University of Illinois at Chicago, College of Pharmacy, 833 S Wood St, MC 886, Room 164, Chicago, IL 60612, USA
    Am J Health Syst Pharm 61:S3-4. 2004
  14. ncbi New anticoagulant agents: direct thrombin inhibitors
    Edith A Nutescu
    Department of Pharmacy Practice, Antithrombosis Center, University of Illinois at Chicago, College of Pharmacy and Medical Center, IL 60612, USA
    Clin Geriatr Med 22:33-56, viii. 2006
    ....
  15. ncbi ASHP therapeutic position statement on antithrombotic therapy in chronic atrial fibrillation
    Edith A Nutescu
    University of Illinois at Chicago College of Pharmacy, 833 South Wood Street, M C 886, Room 164, Chicago, IL 60612, USA
    Am J Health Syst Pharm 64:2281-91. 2007
  16. ncbi Warfarin and its interactions with foods, herbs and other dietary supplements
    Edith A Nutescu
    Department of Pharmacy Practice, University of Illinois, College of Pharmacy, Chicago, IL 60612, USA
    Expert Opin Drug Saf 5:433-51. 2006
    ..Practical steps for patients and providers to minimise these interactions are highlighted...
  17. ncbi Drug evaluation: the directly activated Factor Xa inhibitor otamixaban
    Edith A Nutescu
    Antithrombosis Center, Department of Pharmacy Practice, College of Pharmacy, The University of Illinois at Chicago, Chicago, IL 60612 7230, USA
    IDrugs 9:854-65. 2006
    ..Otamixaban is a promising agent that merits further consideration for clinical trials in patients with coronary thrombosis...
  18. ncbi Anticoagulant agents are mainstay therapies in the prevention and treatment of arterial and venous thrombosis. Introduction
    Edith A Nutescu
    Department of Pharmacy Practice, University of Illinois at Chicago, 833 S Wood St, Rm 164, MC886, Chicago, IL 60612, USA
    Am J Manag Care 12:S427-9. 2006
  19. ncbi Easing the economic burden of acute coronary syndromes: cost-effectiveness of emerging therapies
    Edith A Nutescu
    Department of Pharmacy Practice, University of Illinois at Chicago, 833 S Wood St, Rm 164, MC886, Chicago, IL 60612, USA
    Am J Manag Care 12:S444-50. 2006
    ..Health economic analysis of fondaparinux treatment is currently limited to VTE scenarios but point to a cost benefit associated with fondaparinux compared with enoxaparin...
  20. ncbi Basic terminology in obtaining reimbursement for pharmacists' cognitive services
    Edith A Nutescu
    Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, Chicago, IL 60612, USA
    Am J Health Syst Pharm 64:186-92. 2007
    ..A basic overview and definitions of commonly used billing and reimbursement terminology that pharmacists will need to know to obtain reimbursement for cognitive services are provided...
  21. ncbi Point of care monitors for oral anticoagulant therapy
    Edith A Nutescu
    Department of Pharmacy Practice, College of Pharmacy, The University of Illinois at Chicago, 60612, USA
    Semin Thromb Hemost 30:697-702. 2004
    ..Because technology differs among the various devices, accuracy and precision need to be determined for individual devices. The various devices cannot be used interchangeably, and individual device performance cannot be generalized...
  22. ncbi Drug and dietary interactions of warfarin and novel oral anticoagulants: an update
    Edith Nutescu
    Department of Pharmacy Practice and Center for Pharmacoeconomic Research, University of Illinois at Chicago, College of Pharmacy, 833 S Wood St MC 886, Rm 164, Chicago, IL 60612, USA
    J Thromb Thrombolysis 31:326-43. 2011
    ..The objective of this paper is to give an update on drug and dietary interactions with warfarin and the novel oral anticoagulants, dabigatran, rivaroxaban, apixaban, and edoxaban...
  23. ncbi Traditional versus modern anticoagulant strategies: summary of the literature
    Edith Nutescu
    Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, 833 South Wood Street, M C 886, Chicago, IL 60612, USA
    Am J Health Syst Pharm 59:S7-14. 2002
    ..Primary studies of new agents, including oral direct thrombin inhibitors and synthetic pentasaccharides for the treatment of ACS are promising; however, more data are needed on their safety and efficacy...
  24. ncbi Ezetimibe: a selective cholesterol absorption inhibitor
    Edith A Nutescu
    Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois 60612, USA
    Pharmacotherapy 23:1463-74. 2003
    ..In combination therapy with a statin, ezetimibe is used in patients who cannot tolerate high statin doses or in those who need additional LDL reductions despite maximum statin doses...
  25. ncbi Tinzaparin: considerations for use in clinical practice
    Edith A Nutescu
    Department of Pharmacy Practice, College of Pharmacy, The University of Illinois at Chicago, Chicago, IL, USA
    Ann Pharmacother 37:1831-40. 2003
    ..To evaluate the safety and effectiveness of tinzaparin for the prevention and treatment of venous thromboembolism (VTE)...
  26. ncbi Direct thrombin inhibitors for anticoagulation
    Edith A Nutescu
    Antithrombosis Service, College of Pharmacy, The University of Illinois at Chicago, Chicago, IL 60612, USA
    Ann Pharmacother 38:99-109. 2004
    ..To review the progress in developing direct thrombin inhibitors (DTIs) for anticoagulation within the context of existing anticoagulation therapies...
  27. ncbi The future of anticoagulation clinics
    Edith A Nutescu
    College of Pharmacy, Department of Pharmacy Practice, The University of Illinois at Chicago, Chicago, IL 60612, USA
    J Thromb Thrombolysis 16:61-3. 2003
    ..Comprehensive Antithrombosis Centers (CAC) will most likely manage patients with thrombotic disorders treated with a range of anticoagulant therapies...
  28. ncbi Characteristics of novel anticoagulants and potential economic implications
    Edith Nutescu
    Antithrombosis Center, College of Pharmacy, University of Illinois at Chicago, Chicago, IL 60612, USA
    Am J Manag Care 17:S27-32. 2011
    ..This article will review the characteristics of the new oral anticoagulants, which may potentially translate into cost savings for the healthcare system...
  29. ncbi Assessing, preventing, and treating venous thromboembolism: evidence-based approaches
    Edith A Nutescu
    University of Illinois at Chicago, Department of Pharmacy Practice, Chicago, IL 60612, USA
    Am J Health Syst Pharm 64:S5-13. 2007
    ....
  30. ncbi Evolving concepts in the treatment of venous thromboembolism: the role of factor Xa inhibitors
    Edith A Nutescu
    Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois 60612, USA
    Pharmacotherapy 24:82S-87S. 2004
    ..Fondaparinux is a welcomed addition to the available antithrombotic options...
  31. ncbi Treatment of venous thromboembolism: challenging the unfractionated heparin standard
    Edith Nutescu
    Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois 60612, USA
    Pharmacotherapy 24:127S-131S. 2004
    ..As clinical data regarding these new agents for treatment of VTE continue to evolve, their role in clinical practice will be elucidated...
  32. ncbi New blood thinner offers first potential alternative in 50 years: ximelagatran
    Edith A Nutescu
    Antithrombosis Service, Department of Pharmacy Practice, College of Pharmacy, The University of Illinois at Chicago, 60612, USA
    J Cardiovasc Nurs 19:374-83. 2004
    ..Pending regulatory approval, ximelagatran may help overcome barriers to appropriate anticoagulant therapy, thereby decreasing morbidity and mortality associated with thrombotic diseases...
  33. ncbi Emerging options in the treatment of venous thromboembolism
    Edith A Nutescu
    The University of Illinois at Chicago, College of Pharmacy, 833 S Wood St, MC 886, Room 164, Chicago, IL 60612, USA
    Am J Health Syst Pharm 61:S12-7. 2004
    ....
  34. ncbi Transitioning from traditional to novel anticoagulants: the impact of oral direct thrombin inhibitors on anticoagulation management
    Edith A Nutescu
    Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois 60612, USA
    Pharmacotherapy 24:199S-202S. 2004
    ..Traditional anticoagulation monitoring services will have to retool for the future if they are to remain relevant in the new era of novel antithrombotic.agents...
  35. ncbi Anticoagulation patient self-monitoring in the United States: considerations for clinical practice adoption
    Edith A Nutescu
    Department of Pharmacy Practice and Pharmacy Administration, University of Illinois at Chicago, Chicago, Illinois 60612 7230, USA
    Pharmacotherapy 31:1161-74. 2011
    ..Further studies are needed to explore factors that influence the adoption of self-monitoring in the United States and to evaluate the feasibility and implementation in real-life clinical settings...
  36. ncbi Survey of hospitals for guidelines, policies, and protocols for anticoagulants
    Vikrant Vats
    Center for Pharmacoeconomic Research, College of Pharmacy, University of Illinois at Chicago, Chicago, IL 60612, USA
    Am J Health Syst Pharm 64:1203-8. 2007
    ....
  37. ncbi Oral anticoagulation: preparing for change
    Edith A Nutescu
    University of Illinois at Chicago, College of Pharmacy, Chicago, Illinois, USA
    J Am Med Dir Assoc 5:2-11. 2004
    ..Further, the results of clinical trials suggest that ximelagatran may be as effective as warfarin in preventing stroke and VTE...
  38. ncbi Examining differences in weekly warfarin dose in patients with and without cancer
    Karen M Grogan
    College of Pharmacy, University of Illinois at Chicago, Chicago, IL 60612, USA
    Ther Drug Monit 29:638-43. 2007
    ....
  39. ncbi Predictors of unstable anticoagulation in African Americans
    Larisa H Cavallari
    Department of Pharmacy Practice, University of Illinois at Chicago College of Pharmacy, 833 S Wood St, Room 164, Chicago, IL 60612 7230, USA
    J Thromb Thrombolysis 27:430-7. 2009
    ..We sought to identify contributors to unstable anticoagulation in African Americans...
  40. ncbi Factors that influence prescribing decisions
    Glen T Schumock
    Center for Pharmacoeconomic Research, and Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, IL 60612 7230, USA
    Ann Pharmacother 38:557-62. 2004
    ..Knowledge of these differences could have importance in predicting the effectiveness of strategies designed to influence drug use in this setting...
  41. ncbi Hospital guidelines for use of low-molecular-weight heparins
    Edith A Nutescu
    Antithrombosis Services, University of Illinois at Chicago, Chicago, IL, USA
    Ann Pharmacother 37:1072-81. 2003
    ..To describe the development of guidelines for initial use of low-molecular-weight heparins (LMWHs) and other anticoagulants in acute-care hospitals that are part of a national group purchasing organization (GPO)...
  42. ncbi Impact of prescribing guidelines for inpatient anticoagulation
    Glen T Schumock
    Center for Pharmacoeconomic Research, Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, IL, USA
    Ann Pharmacother 38:1570-5. 2004
    ..As such, these drugs may be amenable to the use of prescribing guidelines. However, relatively little has been published on the effect of such guidelines on clinical outcomes or costs of care...
  43. ncbi Sex difference in the antiplatelet effect of aspirin in patients with stroke
    Larisa H Cavallari
    Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, Chicago, IL 60612 7230, USA
    Ann Pharmacother 40:812-7. 2006
    ..The factors contributing to this variability are not well defined...
  44. ncbi Survey of hospital policies regarding low-molecular-weight heparins
    Glen T Schumock
    Department of Pharmacy Practice, University of Illinois at Chicago, 833 S Wood Street M C 886, Chicago, IL 60612, USA
    Am J Health Syst Pharm 59:534-8. 2002
    ..Policies to promote alternatives to LMWHs were reported by 18% of the respondents. A multihospital survey showed that many hospitals wanted but relatively few had prescribing guidelines for LMWHs...
  45. ncbi Effect of a warfarin adherence aid on anticoagulation control in an inner-city anticoagulation clinic population
    Beth Nochowitz
    Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, IL 60612, USA
    Ann Pharmacother 43:1165-72. 2009
    ..Poor adherence to warfarin therapy is a major contributor to subtherapeutic anticoagulation...
  46. ncbi Burden of deep vein thrombosis in the outpatient setting following major orthopedic surgery
    Edith A Nutescu
    Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, USA
    Ann Pharmacother 42:1216-21. 2008
    ..Recently published orthopedic guidelines have focused on prevention of pulmonary embolism as a primary outcome, but deep vein thrombosis (DVT) occurrence should not be readily dismissed...
  47. ncbi Factors that influence prescribing within a therapeutic drug class
    Edith A Nutescu
    Antithrombosis Services, University of Illinois, Chicago, IL, USA
    J Eval Clin Pract 11:357-65. 2005
    ..The purpose of this study was to identify and compare factors perceived by doctors and clinical pharmacists to be influential in prescribing decisions among LMWHs...
  48. ncbi Influence of cyclooxygenase-1 genotype on ex vivo aspirin response in patients at risk for stroke
    Kathryn M Momary
    Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, Chicago, Ill, USA
    Cerebrovasc Dis 27:585-93. 2009
    ..We sought to determine whether cyclooxygenase-1 (PTGS1) genotype is associated with the ability of aspirin to inhibit platelet aggregation in patients at risk for stroke...
  49. ncbi Antiplatelet therapy in patients with unstable angina and non-ST-segment-elevation myocardial infarction: findings from the CRUSADE national quality improvement initiative
    Michael B Bottorff
    College of Pharmacy, University of Cincinnati Medical Center, Cincinnati, Ohio 45267, USA
    Pharmacotherapy 27:1145-62. 2007
    ..The role of the pharmacist is pivotal in ensuring adherence to clinical guidelines by interacting with both the physician and patient...
  50. ncbi Antithrombotic therapy for the treatment of venous thromboembolism
    Edith A Nutescu
    Department of Pharmacy Practice, The University of Illinois at Chicago, College of Pharmacy, USA
    Am J Manag Care 9:S103-14; quiz S115-20. 2003
    ..Benefit-to-risk analyses will be necessary for determining how effective novel therapies will compare with established regimens...
  51. ncbi Impact of oral direct thrombin inhibitors on anticoagulation clinics
    Edith A Nutescu
    Department of Pharmacy Practice, University of Illinois at Chicago, IL 60612, USA
    Pharmacotherapy 24:1204-12. 2004
    ....
  52. ncbi YM-150, a Factor Xa inhibitor for the prevention of venous thromboembolism and coronary artery disease
    Anna Markel Vaysman
    The University of Illinois at Chicago, Department of Pharmacy Practice, Antithrombosis Center and Center for Pharmacoeconomic Research, College of Pharmacy and Medical Center, 833 S Wood St, M C 886, Chicago, IL 60612, USA
    Curr Opin Investig Drugs 11:333-9. 2010
    ..The phase III trials would assess the efficacy of YM-150 in the prevention of VTE in a larger number of patients...
  53. ncbi Anticoagulation monitoring part 2: Unfractionated heparin and low-molecular-weight heparin
    Sarah A Spinler
    Cardiovascular Division, Department of Medicine, Philadelphia College of Pharmacy, University of Pennsylvania, Philadelphia, PA, USA
    Ann Pharmacother 39:1275-85. 2005
    ..To review the availability, mechanisms, limitations, and clinical application of point-of-care (POC) devices used in monitoring anticoagulation with unfractionated heparin (UFH) and low-molecular-weight heparins (LMWHs)...
  54. ncbi Ximelagatran: an oral direct thrombin inhibitor
    William E Dager
    Department of Pharmaceutical Services, University of California Davis Medical Center, Sacramento, CA, USA
    Ann Pharmacother 38:1881-97. 2004
    ....
  55. ncbi Outcomes of oral anticoagulant therapy managed by telephone vs in-office visits in an anticoagulation clinic setting
    Ann K Wittkowsky
    School of Pharmacy, University of Washington, Seattle, WA, USA
    Chest 130:1385-9. 2006
    ....
  56. ncbi Generic warfarin: implications for clinical practice and perceptions of anticoagulation providers
    Rachel A Bongiorno
    University of Maryland School of Pharmacy, Baltimore, Maryland, USA
    Semin Thromb Hemost 30:619-26. 2004
    ..These perceptions may change over time as additional data showing comparative therapeutic outcomes between generic and brand name formulations are published...
  57. ncbi Antithrombotic therapy and pregnancy: consensus report and recommendations for prevention and treatment of venous thromboembolism and adverse pregnancy outcomes
    Adam J Duhl
    Department of Obstetrics and Gynecology, Mercy Hospital of Pittsburgh, Pittsburgh, PA, USA
    Am J Obstet Gynecol 197:457.e1-21. 2007
    ....
  58. ncbi Anticoagulation monitoring part 1: warfarin and parenteral direct thrombin inhibitors
    Sarah A Spinler
    Cardiovascular Division, Department of Medicine, Philadelphia College of Pharmacy, University of Pennsylvania, Philadelphia, PA 19104 4495, USA
    Ann Pharmacother 39:1049-55. 2005
    ..To review the availability, mechanisms, limitations, and clinical application of point-of-care (POC) devices used in the management of warfarin and parenteral direct thrombin inhibitors...
  59. ncbi Barriers to patient self-testing of prothrombin time: national survey of anticoagulation practitioners
    Ann K Wittkowsky
    School of Pharmacy, University of Washington, Seattle, Washington, USA
    Pharmacotherapy 25:265-9. 2005
    ..7%). Over 75% of respondents believed that some reimbursement for the cost of self-testing devices and supplies would increase the likelihood that anticoagulation clinics would recommend INR self-testing...
  60. ncbi Postdischarge oral versus injectable anticoagulation following major orthopedic surgery
    Andrew F Shorr
    Pulmonary and Critical Care, Washington Hospital Center, Georgetown University, Washington, DC 34685, USA
    Ann Pharmacother 42:1222-8. 2008
    ..Multiple clinical studies have shown postdischarge anticoagulation to be beneficial following major orthopedic surgery (MOS); however, outpatient prophylaxis is not widely practiced...
  61. ncbi Rivaroxaban: an oral direct inhibitor of factor Xa
    Michael P Gulseth
    University of Minnesota College of Pharmacy, Duluth, MN 55812, USA
    Am J Health Syst Pharm 65:1520-9. 2008
    ..The mechanism of action, pharmacodynamics, pharmacokinetics, efficacy in clinical trials, interactions, adverse effects and toxicity, and place in therapy of rivaroxaban are reviewed...
  62. ncbi Factors influencing warfarin dose requirements in African-Americans
    Kathryn M Momary
    Mercer University College of Pharmacy, 3001 Mercer University Dr, Atlanta, GA, 30341 4155, USA
    Pharmacogenomics 8:1535-44. 2007
    ....
  63. ncbi Current and emerging treatment options for venous thrombosis: a case discussion
    Stuart T Haines
    University of Maryland School of Pharmacy, Baltimore, MD, USA
    Am J Health Syst Pharm 62:593-605. 2005
  64. ncbi Uncertain times for oral anticoagulation therapy
    Edith A Nutescu
    Am J Health Syst Pharm 62:1449. 2005
  65. ncbi Different contributions of polymorphisms in VKORC1 and CYP2C9 to intra- and inter-population differences in maintenance dose of warfarin in Japanese, Caucasians and African-Americans
    Harumi Takahashi
    Department of Pharmacotherapy, Meiji Pharmaceutical University, Kiyose, Tokyo, Japan
    Pharmacogenet Genomics 16:101-10. 2006
    ....
  66. ncbi Shifting paradigms in oral anticoagulation management
    Edith A Nutescu
    J Cardiovasc Pharmacol Ther 9:149-50. 2004
  67. ncbi Delivery of optimized anticoagulant therapy: consensus statement from the Anticoagulation Forum
    David A Garcia
    University of New Mexico School of Medicine, Albuquerque, NM, USA
    Ann Pharmacother 42:979-88. 2008
    ....